New avenues for the prevention of colorectal cancer: Targeting cyclo-oxygenase-2 activity

Rajnish A. Gupta, Raymond N. DuBois, Mina C. Wallace

    Research output: Contribution to journalArticlepeer-review

    11 Scopus citations


    Carcinoma of the colon and/or rectum represents the second most common gastrointestinal malignancy worldwide. Despite this prevalence, current therapeutic regimens remain largely ineffectual, particularly when the disease is diagnosed at an advanced stage. Recent work in the field of colorectal cancer has established that a chronic intake of non steroidal anti-inflammatory drugs can reduce the risk of developing colorectal cancer. Although the precise mechanism(s) by which these drugs inhibit tumour growth is not completely understood, it is likely that at least a part of their anti-tumorigenic effects results from an inhibition of the cyclo-oxygenase-2 enzyme. This chapter will focus on this emerging research area and the promise it brings for identifying new strategies for the prevention of colorectal cancer.

    Original languageEnglish (US)
    Pages (from-to)945-956
    Number of pages12
    JournalBailliere's Best Practice and Research in Clinical Gastroenterology
    Issue number6
    StatePublished - Dec 2002


    • Angiogenesis
    • Colon cancer
    • Cyclo-oxygenase
    • Prevention

    ASJC Scopus subject areas

    • Gastroenterology


    Dive into the research topics of 'New avenues for the prevention of colorectal cancer: Targeting cyclo-oxygenase-2 activity'. Together they form a unique fingerprint.

    Cite this